Topic

Virginia

A collection of 501 issues

Aetna (CVS Health)'s Coverage Criteria for Ultomiris (ravulizumab) in Virginia: What Counts as "Medically Necessary"?

Quick Answer: Aetna (CVS Health) requires prior authorization for Ultomiris (ravulizumab) across all FDA-approved indications in Virginia. Submit form GR-69447 with diagnosis-specific labs, REMS compliance proof, and vaccination records. If denied, Virginia's State Corporation Commission provides free external review within 120 days. First step: Verify your coverage and

How to Get Kesimpta (Ofatumumab) Covered by Blue Cross Blue Shield in Virginia: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Kesimpta Covered by BCBS Virginia Anthem Blue Cross Blue Shield Virginia classifies Kesimpta (ofatumumab) as a non-preferred specialty drug requiring prior authorization and step therapy. To get covered, you need: (1) documented relapsing MS diagnosis with recent activity, (2) failure of at least 2 preferred first-line DMTs,

Myths vs. Facts: Getting Mepsevii (Vestronidase Alfa-vjbk) Covered by Humana in Virginia

Quick Answer: Your Path to Mepsevii Coverage Humana requires prior authorization for Mepsevii (vestronidase alfa-vjbk) in Virginia, but approval is possible with confirmed MPS VII diagnosis and specialist documentation. Submit genetic testing results, enzyme assay, and medical necessity letter from a metabolic specialist. Standard decisions take 7-30 days; expedited reviews

If Orfadin (Nitisinone) Isn't Approved by Humana in Virginia: Alternative Coverage Paths and Appeal Strategies

Answer Box: Getting Orfadin (Nitisinone) Covered by Humana in Virginia If Humana denies Orfadin (nitisinone) for hereditary tyrosinemia type 1 (HT-1), your fastest path is a formulary exception request with genetic/biochemical HT-1 confirmation and dietary management documentation. Virginia patients have strong appeal rights through the State Corporation Commission'

How to Get Opsumit (Macitentan) Covered by Cigna in Virginia: Complete Coding and Appeal Guide

Answer Box: Fast Track to Opsumit Coverage in Virginia Getting Opsumit (macitentan) approved by Cigna in Virginia requires prior authorization with proper coding and clinical documentation. Submit PA using ICD-10 codes I27.0 (primary PAH) or I27.21 (secondary PAH), NDC 0078-0661-01, and right heart catheterization results showing WHO Group

The Requirements Checklist to Get Advate (Octocog Alfa) Covered by UnitedHealthcare in Virginia: Forms, Appeals, and Success Strategies

Answer Box: Getting Advate Covered by UnitedHealthcare in Virginia UnitedHealthcare requires prior authorization for Advate (octocog alfa) through OptumRx, with approval based on hemophilia A diagnosis, negative inhibitor testing, and documented bleeding history. Your fastest path to approval: (1) Submit PA request via UnitedHealthcare Provider Portal with ICD-10 code D66,

The Requirements Checklist to Get Ferriprox (deferiprone) Covered by Aetna (CVS Health) in Virginia

Answer Box: Your Path to Ferriprox Coverage To get Ferriprox (deferiprone) covered by Aetna (CVS Health) in Virginia: Submit prior authorization through CVS Caremark with documented transfusional iron overload (ferritin >1,000 mcg/L), prescribed by a hematologist for patients ≥8 years with thalassemia or sickle cell disease. If

How to Get Cabometyx (cabozantinib) Covered by Humana in Virginia: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Cabometyx Covered by Humana in Virginia Cabometyx (cabozantinib) requires prior authorization from Humana in Virginia and is typically covered as a Tier 5 specialty drug under Medicare Advantage Part D plans. The fastest path to approval: 1) Verify your plan's formulary status via the Humana

How to Get Zolgensma (Onasemnogene Abeparvovec) Covered by Blue Cross Blue Shield in Virginia: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Zolgensma Covered in Virginia Zolgensma requires prior authorization from Blue Cross Blue Shield in Virginia. The fastest path to approval: (1) Submit genetic confirmation of bi-allelic SMN1 mutation and negative anti-AAV9 antibodies, (2) Ensure patient is under 24 months old with ≤3 SMN2 copies, and (3) Include

How to Get Oxervate (cenegermin) Covered by Aetna (CVS Health) in Virginia: Complete Prior Authorization and Appeal Guide

Answer Box: Getting Oxervate Covered by Aetna in Virginia Aetna (CVS Health) requires prior authorization for Oxervate (cenegermin) for neurotrophic keratitis. You'll need documented stage 2 or 3 disease (ICD-10 codes H16.231-H16.233), failure of artificial tears, and an ophthalmologist's prescription. Submit through CVS Caremark